A Non-intervention Fiberoptic Bronchoscopy Study of Remazolam Toluene Sulfonate for Injection Under General Anesthesia and Fiberoptic Bronchoscopy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1285 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-18

Study Completion Date

2024-06-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a non-interventional study of remazolam toluenesulfonate (rebenin ®) for injection in Chinese patients. A total of 1000 patients were enrolled in this study based on the preliminary safety assessment of rebenin ®, and all safety information was obtained

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Efficacy of Sufentanil Combined With Midazolam in Bronchoscopy Under Conscious Sedation: Retrospective Study

NCT03890094

Bronchoscopy Sedation

COMPLETED

A Phase Ⅰb Study of Remimazolam Tosylate in Healthy Volunteers

NCT03444480

Anesthesia

COMPLETED PHASE1

A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU

NCT05913336

Sedation in the ICU

COMPLETED PHASE1/PHASE2

A Study of Remimazolam Tosilate for Sedation in the ICU

NCT06222294

Sedation in the ICU

COMPLETED PHASE3

Optimal Effect-site Concentration of Remifentanil for Inhibiting Response to Laryngeal Mask Airway (LMA) Removal

NCT01915108

Respiratory Complication

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

General Anesthesia and Bronchoscopy Sedation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

General anesthesia cohort

Remimazolam Tosilate for Injection

Intervention Type DRUG

Remimazolam Tosilate for Injection

Bronchoscopy sedation cohort

Remimazolam Tosilate for Injection

Intervention Type DRUG

Remimazolam Tosilate for Injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remimazolam Tosilate for Injection

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients using rebinim ® during general anesthesia and fiberoptic sedation
2. Patients need to sign informed consent

Exclusion Criteria

1. Patients who are participating in or planning to participate in any interventional clinical trial
2. The investigator considers that there are any other reasons for the patient's ineligibility for the study

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes